Company Homeomed Srl with Fiscal Code 16067503
recorded a turnover of 2024 of
101.501,
with a net profit of
51.261
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Homeomed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
24.094
26.162
29.122
35.170
51.686
59.842
55.479
62.556
74.195
101.501
Total Income - EUR
24.094
26.163
29.123
35.171
51.686
62.943
55.480
62.556
74.197
101.909
Total Expenses - EUR
20.726
20.585
23.264
24.860
24.512
31.769
31.774
30.156
39.280
47.590
Gross Profit/Loss - EUR
3.368
5.577
5.858
10.311
27.174
31.174
23.705
32.400
34.916
54.319
Net Profit/Loss - EUR
2.645
5.316
5.531
9.963
26.657
30.985
23.217
31.809
34.226
51.261
Employees
4
4
3
3
3
3
3
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 37.6%, from 74.195 euro in the year 2023, to 101.501 euro in 2024.
The Net Profit increased by 17.227 euro, from 34.226 euro in 2023, to 51.261 in the last year.
Check the financial reports for the company - Homeomed Srl
Financial Rating - HOMEOMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Homeomed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Homeomed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Homeomed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
50.665 euro in 2024 which includes Inventories of
0 euro, Receivables of
38.889 euro and cash availability of
11.776 euro.
The company's Equity was valued at
51.310 euro, while total Liabilities amounted to
3.858 euro.
Equity increased by 17.227 euro, from 34.275 euro in 2023, to 51.310 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Homeomed Srl